Middle EAST Antiinfective Drug Market Analysis Report: Growth Factors, Challenges, and Opportunities
The Middle EAST Antiinfective Drug Market was valued at USD 5.2 billion in 2024 and is projected to reach USD 9.8 billion by 2034, registering a CAGR of 6.5%. This growth trajectory is underpinned by several factors, including the rising incidence of infectious diseases, increasing healthcare expenditure, and the growing demand for advanced therapeutic options. The region has witnessed a surge...
0 Yorumlar 0 hisse senetleri 37 Views 0 önizleme